Question 1

Does Jacobs Levy Equity Management own REGN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Jacobs Levy Equity Management holds 256,503 shares of REGN (Regeneron Pharmaceuticals), worth $159.9M.

Question 2

How many shares of REGN does Jacobs Levy Equity Management own?

Accepted Answer

As of its Q2 2026 13F, Jacobs Levy Equity Management holds 256,503 shares of REGN (Regeneron Pharmaceuticals).

Question 3

What is Jacobs Levy Equity Management's REGN position worth?

Accepted Answer

As of its Q2 2026 13F, Jacobs Levy Equity Management's REGN position is worth $159.9M.

Question 4

Is Jacobs Levy Equity Management buying or selling REGN?

Accepted Answer

In Q2 2026, Jacobs Levy Equity Management increased its REGN position by 42,343 shares (+19.8%).

Question 5

When did Jacobs Levy Equity Management first buy REGN?

Accepted Answer

Jacobs Levy Equity Management first reported REGN in its Q4 2021 13F and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	256,503	+19.8%	$159.9M	0.6%	$622.81	51
2026-Q1	Decreased	214,160	-19.2%	$165.5M	0.7%	$770.59	0
2025-Q4	Decreased	264,991	-8.0%	$204.5M	0.8%	$768.90	0
2025-Q3	Increased	287,881	+22.9%	$161.9M	0.6%	$559.40	52
2025-Q2	Increased	234,267	+313x	$123M	0.5%	$521.53	58
2025-Q1	Decreased	747	-11.8%	$473,770	0.0%	$629.11	0
2024-Q4	Decreased	847	-96.4%	$603,344	0.0%	$705.67	0
2024-Q3	Increased	23,591	+76.3%	$24.8M	0.1%	$1,041.41	43

REGNShowing 8 of 13 quarters

REGN
Showing 8 of 13 quarters